Predictors of the outcomes of acute-on-chronic hepatitis B liver failure

World Journal of Gastroenterology

Volumn 18, Issue 36, 2012, Pages 5078-5083

  Fan, Hsiu Lung ^a   Yang, Po Sheng ^b   Chen, Hui Wei ^c   Chen, Teng Wei ^a   Chan, De Chuan ^a   Chu, Chi Hong ^a   Yu, Jyh Cherng ^a   Kuo, Shih Ming ^a   Hsieh, Chung Bao ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute Physiology and Chronic Health Evaluation II score; Hepatitis B virus; Lamivudine; Liver failure; Model for end stage liver disease scores

Indexed keywords

LAMIVUDINE;

ACUTE ON CHRONIC LIVER FAILURE HEPATITIS B VIRUS; ADULT; ANTIVIRAL THERAPY; APACHE; ARTICLE; BLOOD CULTURE; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS;

EID: 84867836653     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i36.5078     Document Type: Article

References (26)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 1486-1500
2. Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346: 1682-1683
3. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282
4. Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006; 13: 256-263
5. Yu JW, Sun LJ, Zhao YH, Kang P, Li SC. The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci 2010; 55: 775-783
6. Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, Safadi R, Lurie Y, Rosner G, Tur-Kaspa R, Reshef R. Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int 2004; 24: 547-551
7. Chan HL, Tsang SW, Hui Y, Leung NW, Chan FK, Sung JJ. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice. J Viral Hepat 2002; 9: 424-428
8. Zhu X, Chen G, He X, Lu M, Wang G, Cai C, Yang Y, Huang J. Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China. Chin Med Sci J 2002; 17: 44-46
9. Liu CL, Fan ST, Lo CM, Wei WI, Yong BH, Lai CL, Wong J. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation 2003; 76: 1174-1179
10. Chen Z, Zeng Y, Wen TF, Gong S, Zhao JC, Li B, Wang WT, Xu MQ, Yang J, Wu H, Yan LN. Dual grafts live donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplant Proc 2010; 42: 4552-4554
11. Yu JW, Wang GQ, Zhao YH, Sun LJ, Wang SQ, Li SC. The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment. Hepatobiliary Pancreat Dis Int 2007; 6: 492-496
12. Weng ZH, Cai SQ. Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease. World J Gastroenterol 2005; 11: 899-902
13. Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 2009; 16: 464-470
14. Chatzicostas C, Roussomoustakaki M, Notas G, Vlachonikolis IG, Samonakis D, Romanos J, Vardas E, Kouroumalis EA. A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosis. BMC Gastroenterol 2003; 3: 7
15. Ho YP, Chen YC, Yang C, Lien JM, Chu YY, Fang JT, Chiu CT, Chen PC, Tsai MH. Outcome prediction for critically ill cirrhotic patients: a comparison of APACHE II and Child-Pugh scoring systems. J Intensive Care Med 2004; 19: 105-110
16. Tsai MH, Chen YC, Ho YP, Fang JT, Lien JM, Chiu CT, Liu NJ, Chen PC. Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients. J Clin Gastroenterol 2003; 37: 251-257
17. Gagliardi G, Laccania G, Boscolo A, La Guardia P, Arrigoni M, Michielan F. Intensive care unit management of fulminant hepatic failure. Transplant Proc 2006; 38: 1389-1393
18. Park KM, Kim KH, Lee SG, Lee YJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim HJ. Clinical value of APACHE scores in patients who require intensive care before liver transplantation. Hepatogastroenterology 2008; 55: 2135-2139
19. Keegan MT, Gali B, Findlay JY, Heimbach JK, Plevak DJ, Afessa B. APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study. BMC Surg 2009; 9: 11
20. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
22. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006; 163: 670-675
23. Sun LJ, Yu JW, Zhao YH, Kang P, Li SC. Influential factors of prognosis in lamivudine treatment for patients with acuteon-chronic hepatitis B liver failure. J Gastroenterol Hepatol 2010; 25: 583-590
24. Freeman RB. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl 2004; 10: S2-S3
25. Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu ML. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors. Clin Ther 2006; 28: 2081-2092
26. Yu JW, Sun LJ, Zhao YH, Li SC. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol 2008; 23: 1242-1249